C.M. Bidwell & Associates’s Pediatrix Medical MD Stock Holding History

C.M. Bidwell & Associates’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.55K	Hold	377	–	–	﹤0.01%	294
2026 Q1	$8.06K	Sell	377 -6,653	-95%	-$138K	﹤0.01%	293
2025 Q4	$150K	Buy	7,030 +75	+1%	+$1.54K	0.07%	159
2025 Q3	$116K	Sell	6,955 -10	-0.1%	-$150	0.06%	168
2025 Q2	$99.9K	Hold	6,965	–	–	0.05%	171
2025 Q1	$101K	Sell	6,965 -135	-2%	-$1.92K	0.06%	162
2024 Q4	$93.2K	Sell	7,100 -92	-1%	-$1.27K	0.06%	175
2024 Q3	$83.4K	Buy	+7,192	New	+$67.8K	0.05%	187
2023 Q4	–	Sell	-177	Closed	-$2.25K	–	538
2023 Q3	$2.25K	Buy	+177	New	+$2.43K	﹤0.01%	444
2018 Q2	–	Sell	-4,990	Closed	-$278K	–	431
2018 Q1	$278K	Buy	+4,990	New	+$274K	0.25%	113

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

C.M. Bidwell & Associates's MD Position: Q2 2026 in Review

C.M. Bidwell & Associates held its Pediatrix Medical (MD) position steady in Q2 2026 at 377 shares worth $9.55K. The position accounts for ﹤0.01% of the portfolio, ranked #294.

C.M. Bidwell & Associates first reported a position in MD in Q1 2018 and has held it in 10 quarters since. The position peaked at $278K in Q1 2018. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

C.M. Bidwell & Associates held 377 shares of Pediatrix Medical worth $9.55K as of Q2 2026.
C.M. Bidwell & Associates left its Pediatrix Medical share count unchanged in Q2 2026.
Pediatrix Medical made up ﹤0.01% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #294 holding.
C.M. Bidwell & Associates first reported a position in Pediatrix Medical in Q1 2018 and has held it in 10 quarters since.
C.M. Bidwell & Associates's Pediatrix Medical position peaked at $278K in Q1 2018.
304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.